News | March 28, 2011

SNM Enhances Education Program for 2011 Annual Meeting

March 28, 2011 – The Society of Nuclear Medicine’s (SNM) 2011 Annual Meeting, June 4-8 in San Antonio, offers a variety of new education options to nuclear medicine and molecular imaging professionals. With new topics, formats and technologies, the meeting provides a comprehensive review of the latest research and issues in the field.

"In planning the education offerings for the annual meeting, we look to provide attendees with programming that will increase their professional effectiveness, allowing them to examine and evaluate future directions in nuclear medicine, molecular imaging and therapy from both research and clinical perspectives,” said Peter Herscovitch, M.D., chair of SNM’s scientific program committee. “The program combines the latest advances in basic sciences with state of the art reviews of oncology, cardiology and neurology applications."

This year, new topics at SNM include healthcare reform, the future of nuclear medicine from the physicians’ perspective, an update on radioimmunotherapy and use of generator-produced Ga-68. Three hybrid sessions — featuring a mix of basic science, translational and clinical approaches — will be presented on breast cancer, neuroimaging and infection.

In addition, SNM will host several courses on dose reduction and radiation safety. Continuing education courses developed by SNM include those on pediatric dose reduction, reducing patient radiation exposure while improving diagnostic testing, standards of excellence and more.

For the first time, SNM will host a Nuclear Cardiology Technology workshop. There will also be six integrated scientific sessions — sessions that combine abstract presentations with a featured guest speaker. Self-assessment modules for the maintenance of certification program will be back as well.

During the plenary sessions, questions will be taken via text message and Twitter. Also new, SNM will capture 70 sessions and post them online as a virtual meeting available afterwards. The virtual meeting, with pre-meeting, on-site and post-meeting pricing, will include 35 continuing education sessions, 20 technologist sessions and 15 scientific sessions.

"SNM strives improve its content each year, adapting to the changing needs of nuclear medicine and molecular imaging professionals," said Herscovitch. "We have a strong program this year and look forward to a successful meeting."

The SNM Annual Meeting is the foremost educational and networking event in molecular imaging and nuclear medicine. The meeting attracts more than 5,000 scientists, physicians, pharmacists and technologists in the molecular imaging and nuclear medicine fields.

Attendees can choose full meeting registration or a weekend-only registration. Registration is required to receive credit for attending the sessions.

For more information: www.snm.org/am2011

Related Content

MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages
PET Imaging Offers New Possibilities in Chronic Liver Disease Management

Hepatic 18F-FDG, 18F-FAC, and 18F-DFA accumulation are affected in a mouse model of autoimmune hepatitis. (A) Histochemical and immunohistochemical analyses of liver sections from vehicle- and ConA-treated mice. Scale bars represent 50 microns. Transverse PET/CT images (B) and quantification (C) of vehicle- and ConA-treated mice injected with 18F-FDG, 18F-FAC, and 18FDFA. Livers are outlined in a white dotted line. Quantification represents radiotracer accumulation in the liver normalized to a background organ. Image courtesy of Salas J.R., Chen B.Y., Wong A., et al.

News | PET Imaging | October 24, 2018
While liver biopsies are powerful and reliable, they are also invasive, painful, limited and subject to complications....
CORAR Supports Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2018
News | Radiopharmaceuticals and Tracers | October 12, 2018
October 12, 2018 — The Council on Radionuclides and Radiopharmaceuticals Inc.
Huntsman Cancer Institute Installs First Preclinical nanoScan 3T PET/MRI in U.S.
News | PET-MRI | October 10, 2018
The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute (HCI) at the University of Utah in Salt Lake...
Technology and Radionucleotide Development Will Fuel Mobile Gamma Camera Adoption
News | Nuclear Imaging | September 27, 2018
Advancements in healthcare technology, particularly in the surgery category, have led to an increasing adoption of...
Bruker Introduces New High-Performance Preclinical PET/CT Si78 System
Technology | PET-CT | September 26, 2018
September 26, 2018 — Bruker recently announced the introduction of the new preclinical...
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
The Siemens Biograph Vision PET-CT system was released in mid-2018.

The Siemens Biograph Vision PET-CT system was released in mid-2018.

Feature | Nuclear Imaging | September 07, 2018 | By Dave Fornell
Nuclear imaging technology for both single photon emission computed tomography (SPECT) and positron emission tomography...
PET Imaging Agent Predicts Brain Tau Pathology, Alzheimer's Diagnosis
News | PET Imaging | September 05, 2018
Eli Lilly and Co. and Avid Radiopharmaceuticals Inc. announced a Phase 3 study of positron emission tomography (PET)...